- Home
- KLTO vs CHEK Comparison
KLTO vs CHEK Comparison
Compare KLTO & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- CHEK
- Stock Information
- Founded
- KLTO 2019
- CHEK 2004
- Country
- KLTO United States
- CHEK Israel
- Employees
- KLTO N/A
- CHEK N/A
- Industry
- KLTO
- CHEK Medical Electronics
- Sector
- KLTO
- CHEK Health Care
- Exchange
- KLTO NYSE
- CHEK Nasdaq
- Market Cap
- KLTO 9.8M
- CHEK 9.0M
- IPO Year
- KLTO N/A
- CHEK 2015
- Fundamental
- Price
- KLTO $0.38
- CHEK $0.77
- Analyst Decision
- KLTO
- CHEK
- Analyst Count
- KLTO 0
- CHEK 0
- Target Price
- KLTO N/A
- CHEK N/A
- AVG Volume (30 Days)
- KLTO 185.8K
- CHEK 72.4K
- Earning Date
- KLTO 03-04-2025
- CHEK 03-04-2025
- Dividend Yield
- KLTO N/A
- CHEK N/A
- EPS Growth
- KLTO N/A
- CHEK N/A
- EPS
- KLTO N/A
- CHEK N/A
- Revenue
- KLTO N/A
- CHEK N/A
- Revenue This Year
- KLTO N/A
- CHEK N/A
- Revenue Next Year
- KLTO N/A
- CHEK N/A
- P/E Ratio
- KLTO N/A
- CHEK N/A
- Revenue Growth
- KLTO N/A
- CHEK N/A
- 52 Week Low
- KLTO $0.26
- CHEK $0.56
- 52 Week High
- KLTO $13.10
- CHEK $3.45
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- CHEK 38.09
- Support Level
- KLTO N/A
- CHEK $0.81
- Resistance Level
- KLTO N/A
- CHEK $0.92
- Average True Range (ATR)
- KLTO 0.00
- CHEK 0.08
- MACD
- KLTO 0.00
- CHEK -0.01
- Stochastic Oscillator
- KLTO 0.00
- CHEK 22.17
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.